Literature DB >> 16364545

Effects of fluoxetine on cellular immune response in stressed mice.

María J Núñez1, José Balboa, Elena Rodrigo, Julio Brenlla, Mercedes González-Peteiro, Manuel Freire-Garabal.   

Abstract

We studied the effects of fluoxetine, a non-tricyclic antidepressant drug that selectively inhibits re-uptake of serotonin by presinaptic neurons in the brain, on cellular immune responses in mice exposed to a chronic auditory stressor. The natural killer (NK) cell activity was reduced after 4, 8, 12, 16 and 20 days of stress exposure with a partial recovery on days 16 and 20. Daily treatment with fluoxetine partially reversed these adverse effects of stress in a dose-dependent manner. Significant differences appeared when fluoxetine was administered at 2 mg/kg and maximum effect was reached at doses of 5 mg/kg. The capacity of T cells to generate cytotoxic T-lymphocytes (CTL) in mixed lymphocyte cultures and in vivo was reduced after 4 days of stress application and this effect was partially reduced when mice were injected with 5 mg/kg of fluoxetine. Nevertheless, in our experiments, fluoxetine did not significantly affect the cellular immunity in unstressed mice. In conclusion, fluoxetine seems to partially recover the adverse effects of chronic stress on cellular immune response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16364545     DOI: 10.1016/j.neulet.2005.11.042

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  Fluoxetine Maintains a State of Heightened Responsiveness to Motor Training Early After Stroke in a Mouse Model.

Authors:  Kwan L Ng; Ellen M Gibson; Robert Hubbard; Juemin Yang; Brian Caffo; Richard J O'Brien; John W Krakauer; Steven R Zeiler
Journal:  Stroke       Date:  2015-08-20       Impact factor: 7.914

2.  Constitutive activity of 5-HT2C receptors is present after incomplete spinal cord injury but is not modified after chronic SSRI or baclofen treatment.

Authors:  V M Tysseling; D A Klein; R Imhoff-Manuel; M Manuel; C J Heckman; M C Tresch
Journal:  J Neurophysiol       Date:  2017-09-06       Impact factor: 2.714

3.  Fluoxetine ameliorates imbalance of redox homeostasis and inflammation in an acute kidney injury model.

Authors:  Ugur Aksu; Ibrahim Guner; Onur M Yaman; Hayriye Erman; Duygu Uzun; Meliha Sengezer-Inceli; Ahmet Sahin; Nermin Yelmen; Remisa Gelisgen; Hafize Uzun; Gulderen Sahin
Journal:  J Physiol Biochem       Date:  2014-10-01       Impact factor: 4.158

4.  Effects of psychological stress and fluoxetine on development of oral candidiasis in rats.

Authors:  María J Núñez; Silvia Novío; Juan Antonio Suárez; José Balboa; Manuel Freire-Garabal
Journal:  Clin Vaccine Immunol       Date:  2010-02-03

5.  Effect of fluoxetine on disease progression in a mouse model of ALS.

Authors:  J E Koschnitzky; K A Quinlan; T J Lukas; E Kajtaz; E J Kocevar; W F Mayers; T Siddique; C J Heckman
Journal:  J Neurophysiol       Date:  2014-03-05       Impact factor: 2.714

6.  Auditory stimulation of opera music induced prolongation of murine cardiac allograft survival and maintained generation of regulatory CD4+CD25+ cells.

Authors:  Masateru Uchiyama; Xiangyuan Jin; Qi Zhang; Toshihito Hirai; Atsushi Amano; Hisashi Bashuda; Masanori Niimi
Journal:  J Cardiothorac Surg       Date:  2012-03-23       Impact factor: 1.637

7.  Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain.

Authors:  Ibrahim Eren; Mustafa Naziroğlu; Arif Demirdaş
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 4.414

8.  Repurposing Selective Serotonin Reuptake Inhibitors for COVID-19: Rationale and Concerns.

Authors:  Karthick Navin; Pooja Patnaik Kuppili; Vikas Menon
Journal:  Indian J Psychol Med       Date:  2020-11-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.